Terence Kwan

Terence Kwan's work experience includes serving as the Director of Project Management at Clover Biopharmaceuticals since October 2022. Prior to that, they held the position of Senior Manager in CMC Portfolio Management at the company from September 2021 to October 2022.

Before joining Clover Biopharmaceuticals, Terence worked at Avalon SteriTech as a Senior Manager in Science from February 2021 to August 2021. Prior to that, they served as an Assistant Manager in Corporate Strategy and Development from May 2020 to February 2021.

From November 2019 to August 2021, Terence worked at Athenex as an Assistant Project Manager and Senior Scientist, where they led and executed various preclinical pharmaceutical development processes. Terence also worked as an Assistant Project Manager from April 2019 to November 2019 and as a Scientist from September 2018 to March 2019 at Athenex.

Terence also has experience as a Technical Manager at Vanway Pharmaceuticals Holdings Ltd from October 2016 to September 2018, where they led the company's R&D processes and supported pre-IPO activities.

Terence had a brief secondment at New Path Molecular Research as a Research Scientist from October 2016 to September 2017.

Terence worked as a Consultant at Oxbridge Biotech Roundtable from April 2015 to November 2015. Terence was responsible for identifying key features in existing external innovation models and delivering proposals to senior management in the pharmaceutical industry.

Terence's earliest work experience was at the University of Cambridge, where they served as an Undergraduate Academic Supervisor from October 2012 to June 2015. Here, they organized and delivered tutorials for undergraduate chemists while developing targeted teaching plans.

Terence Kwan completed their education at the University of Cambridge. Terence earned a Master of Science (M.Sc.) in Natural Sciences from 2008 to 2012 and went on to obtain a Doctor of Philosophy (Ph.D.) in Organic Chemistry from 2012 to 2016.